Related Experiment Videos
Term pregnancy after three trophoblastic disease events
1Department of Obstetrics and Gynaecology, University of the Witwatersrand, Johannesburg, South Africa.
Gynecologic Oncology
|February 1, 1988
Summary
A successful pregnancy occurred after treatment for two hydatidiform moles and choriocarcinoma using the EMA-CO regimen. This marks the first pregnancy reported after etoposide administration for gestational trophoblastic neoplasia.
Area of Science:
- Reproductive Medicine
- Gynecologic Oncology
- Pharmacology
Background:
- Gestational trophoblastic neoplasia (GTN) encompasses a spectrum of placental-derived tumors, including hydatidiform mole and choriocarcinoma.
- Treatment for high-risk GTN often involves multi-agent chemotherapy, with EMA-CO (etoposide, methotrexate, dactinomycin, cyclophosphamide, vincristine) being a standard regimen.
- Reproductive outcomes following GTN treatment are a significant concern for patients.
Observation:
- A patient with a history of two hydatidiform moles and a subsequent choriocarcinoma was treated with the EMA-CO chemotherapy regimen.
- The patient achieved remission of the choriocarcinoma following the prescribed treatment course.
Findings:
- The patient successfully conceived and carried a pregnancy to term following completion of EMA-CO therapy.
- This represents the first documented successful pregnancy in a patient treated with etoposide-containing chemotherapy for GTN.
Implications:
- This case demonstrates the feasibility of achieving a successful pregnancy after multi-agent chemotherapy for high-risk GTN, including etoposide.
- It offers hope and valuable clinical data for women diagnosed with GTN who desire future fertility.
- Further research into reproductive outcomes and potential long-term effects in patients treated with etoposide is warranted.